Antibacterial, antifungal and cytotoxic evaluation of some new 2,3-disubstituted 4(3H)-quinazolinone derivatives
In this study antibacterial, antifungal and cytotoxic effects of some new 2,3-disubstituted 4(3H)-quinazolinone derivatives have been evaluated. The in vitro antibacterial and antifungal tests of new synthesized compounds were performed using MABA method against six strains of bacteria (three Grampo...
Saved in:
Published in | Research in pharmaceutical sciences Vol. 7; no. 3; pp. 151 - 158 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Iran
Medknow Publications & Media Pvt Ltd
01.07.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | In this study antibacterial, antifungal and cytotoxic effects of some new 2,3-disubstituted 4(3H)-quinazolinone derivatives have been evaluated. The in vitro antibacterial and antifungal tests of new synthesized compounds were performed using MABA method against six strains of bacteria (three Grampositive and three Gram-negative) and three strains of fungi. Also Minimum Bactericidal Concentration (MBC) and Minimum Fungicidal Concentration (MFC) tests were performed. All synthesized compounds indicated mild antibacterial effects especially against Gram-negative bacteria. The most sensitive bacteriumwas E. coli. All strains of tested fungi were sensitive to the synthesized compounds mostly at 32 μg/ml and there was no significant differences in the sensitivity of the tested compounds. MBC and MFC data indicated that tested compounds act as bactriostatic and fungistatic agents. Cytotoxic activity of the compounds was screened at 1, 10 and 100 μM concentrations against HeLa cells using the MTT colorimetric assay. While the synthesized compounds did not show significant cytotoxic activities, compounds 7a(3) and 7a(4) reduced cell viability to about 50% at 100 μM concentration. The present study revealed that most of the new synthesized compounds possess good antifungal effects and they could be considered as valuable candidates for further structural modification to design more potent antifungal agents. |
---|---|
AbstractList | In this study antibacterial, antifungal and cytotoxic effects of some new 2,3-disubstituted 4(3H)-quinazolinone derivatives have been evaluated. The in vitro antibacterial and antifungal tests of new synthesized compounds were performed using MABA method against six strains of bacteria (three Grampositive and three Gram-negative) and three strains of fungi. Also Minimum Bactericidal Concentration (MBC) and Minimum Fungicidal Concentration (MFC) tests were performed. All synthesized compounds indicated mild antibacterial effects especially against Gram-negative bacteria. The most sensitive bacteriumwas E. coli. All strains of tested fungi were sensitive to the synthesized compounds mostly at 32 μg/ml and there was no significant differences in the sensitivity of the tested compounds. MBC and MFC data indicated that tested compounds act as bactriostatic and fungistatic agents. Cytotoxic activity of the compounds was screened at 1, 10 and 100 μM concentrations against HeLa cells using the MTT colorimetric assay. While the synthesized compounds did not show significant cytotoxic activities, compounds 7a(3) and 7a(4) reduced cell viability to about 50% at 100 μM concentration. The present study revealed that most of the new synthesized compounds possess good antifungal effects and they could be considered as valuable candidates for further structural modification to design more potent antifungal agents. In this study antibacterial, antifungal and cytotoxic effects of some new 2,3-disubstituted 4(3H)-quinazolinone derivatives have been evaluated. The in vitro antibacterial and antifungal tests of new synthesized compounds were performed using MABA method against six strains of bacteria (three Grampositive and three Gram-negative) and three strains of fungi. Also Minimum Bactericidal Concentration (MBC) and Minimum Fungicidal Concentration (MFC) tests were performed. All synthesized compounds indicated mild antibacterial effects especially against Gram-negative bacteria. The most sensitive bacteriumwas E. coli . All strains of tested fungi were sensitive to the synthesized compounds mostly at 32 μg/ml and there was no significant differences in the sensitivity of the tested compounds. MBC and MFC data indicated that tested compounds act as bactriostatic and fungistatic agents. Cytotoxic activity of the compounds was screened at 1, 10 and 100 μM concentrations against HeLa cells using the MTT colorimetric assay. While the synthesized compounds did not show significant cytotoxic activities, compounds 7a 3 and 7a 4 reduced cell viability to about 50% at 100 μM concentration. The present study revealed that most of the new synthesized compounds possess good antifungal effects and they could be considered as valuable candidates for further structural modification to design more potent antifungal agents. |
Author | Khajouei, M Rahmani Hassanzadeh, F Jafari, E Khodarahmi, G A Hakimelahi, G H Abedi, D |
AuthorAffiliation | 2 Isfahan Pharmaceutical Sciences Research Center, Isfahan, I.R.Iran 4 Department of Biotechnology and Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Science, Isfahan University of Medical Sciences, Isfahan, I.R.Iran 1 Department of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Science, Isfahan University of Medical Sciences, Isfahan, I.R.Iran 3 Institute of Chemistry, Academia Sinica, Nankang, Taipei, Taiwan |
AuthorAffiliation_xml | – name: 4 Department of Biotechnology and Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Science, Isfahan University of Medical Sciences, Isfahan, I.R.Iran – name: 1 Department of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Science, Isfahan University of Medical Sciences, Isfahan, I.R.Iran – name: 2 Isfahan Pharmaceutical Sciences Research Center, Isfahan, I.R.Iran – name: 3 Institute of Chemistry, Academia Sinica, Nankang, Taipei, Taiwan |
Author_xml | – sequence: 1 givenname: G A surname: Khodarahmi fullname: Khodarahmi, G A organization: Department of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Science, Isfahan University of Medical Sciences, Isfahan, I.R.Iran. ; Isfahan Pharmaceutical Sciences Research Center, Isfahan, I.R.Iran – sequence: 2 givenname: M Rahmani surname: Khajouei fullname: Khajouei, M Rahmani – sequence: 3 givenname: G H surname: Hakimelahi fullname: Hakimelahi, G H – sequence: 4 givenname: D surname: Abedi fullname: Abedi, D – sequence: 5 givenname: E surname: Jafari fullname: Jafari, E – sequence: 6 givenname: F surname: Hassanzadeh fullname: Hassanzadeh, F |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23181093$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkN9LwzAQx4tM3Jz7FySPE1bIrzbpizCGOkHwRZ9LmqQz0iZdk1TnX2_FKXov9z3u7vM97jyZWGf1STJDjGRpQRGdHHVGcjxNFt6_wjFogVmBz5IpJogjWJBZ0q1tMJWQQfdGNCsgxrKOdieaUSogD8EF924k0INoogjGWeBq4F2rgdVvAK9IqoyPlQ8mxKAVoEuyvUr30Vjx4RrzdRlQI30YlwftL5LTWjReL455njzf3jxttunD4939Zv2QdjjPQ5ojWSCqCaxzpRhTlFGGKoozhmvFOacF4RxjxbiACNWccolkLXGluaY0g2SeXH9zu1i1WkltQy-asutNK_pD6YQp_3eseSl3bihJBlGB6QhYHgG920ftQ9kaL3XTCKtd9CXCGGYMQozG0cu_Xr8mP28mn2ssfjQ |
ContentType | Journal Article |
Copyright | Copyright: © Journal of Research in Pharmaceutical Sciences 2012 |
Copyright_xml | – notice: Copyright: © Journal of Research in Pharmaceutical Sciences 2012 |
DBID | NPM 7X8 5PM |
DatabaseName | PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1735-9414 |
EndPage | 158 |
ExternalDocumentID | 23181093 |
Genre | Journal Article |
GroupedDBID | --- 5VS ABDBF ABXLX ACGFS ADBBV ADRAZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL DIK EOJEC ESX GROUPED_DOAJ GX1 H13 HYE IAO IEA IHR ITC KQ8 KWQ M48 MK0 M~E NPM O5R O5S OBODZ OK1 OVD P2P PGMZT RMW RNS RPM TEORI TR2 TUS W3E 7X8 5PM |
ID | FETCH-LOGICAL-p266t-61c914e30f6dd77d47471b42572fd8884938822d78a011f848c1cfc2be8e44503 |
IEDL.DBID | RPM |
ISSN | 1735-5362 |
IngestDate | Tue Sep 17 21:18:29 EDT 2024 Fri Aug 16 00:46:05 EDT 2024 Sat Sep 28 07:59:53 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Cytotoxicity Antifungal 4(3H)-Quinazolinone Antibacterial |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-p266t-61c914e30f6dd77d47471b42572fd8884938822d78a011f848c1cfc2be8e44503 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501924/ |
PMID | 23181093 |
PQID | 1220570021 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3501924 proquest_miscellaneous_1220570021 pubmed_primary_23181093 |
PublicationCentury | 2000 |
PublicationDate | 2012-Jul |
PublicationDateYYYYMMDD | 2012-07-01 |
PublicationDate_xml | – month: 07 year: 2012 text: 2012-Jul |
PublicationDecade | 2010 |
PublicationPlace | Iran |
PublicationPlace_xml | – name: Iran – name: India |
PublicationTitle | Research in pharmaceutical sciences |
PublicationTitleAlternate | Res Pharm Sci |
PublicationYear | 2012 |
Publisher | Medknow Publications & Media Pvt Ltd |
Publisher_xml | – name: Medknow Publications & Media Pvt Ltd |
References | 17978522 - Chem Pharm Bull (Tokyo). 2007 Nov;55(11):1615-9 20599299 - Eur J Med Chem. 2010 Sep;45(9):4188-98 6606682 - J Immunol Methods. 1983 Dec 16;65(1-2):55-63 21194809 - Eur J Med Chem. 2011 Feb;46(2):691-703 18614258 - Eur J Med Chem. 2009 Mar;44(3):1188-97 19541484 - Bioorg Med Chem Lett. 2009 Aug 1;19(15):4196-200 17962771 - Molecules. 2006;11(6):383-92 19109016 - Bioorg Med Chem Lett. 2009 Feb 1;19(3):800-2 10748620 - Pharm Acta Helv. 1999 Dec;74(1):11-7 2536729 - J Biol Chem. 1989 Feb 15;264(5):2973-8 17978766 - Molecules. 2007;12(10):2413-26 20350811 - Bioorg Med Chem. 2010 Apr 15;18(8):2849-63 12849729 - Toxicol In Vitro. 2003 Aug;17(4):457-63 23181076 - Res Pharm Sci. 2012 Jan;7(1):23-30 12951471 - Biol Pharm Bull. 2003 Sep;26(9):1278-82 15780632 - Bioorg Med Chem Lett. 2005 Apr 1;15(7):1915-7 15733846 - FEBS Lett. 2005 Feb 28;579(6):1389-93 15072839 - Eur J Med Chem. 2004 Apr;39(4):299-304 8567901 - J Clin Microbiol. 1995 Oct;33(10):2660-4 20510483 - Eur J Med Chem. 2010 Aug;45(8):3365-73 2549608 - Rev Infect Dis. 1989 Jul-Aug;11 Suppl 5:S902-11 17981366 - Eur J Med Chem. 2008 Jul;43(7):1478-88 18603337 - Eur J Med Chem. 2009 May;44(5):2328-33 11354375 - Bioorg Med Chem Lett. 2001 May 7;11(9):1193-6 8897159 - J Clin Microbiol. 1996 Nov;34(11):2654-9 |
References_xml | |
SSID | ssj0000492792 |
Score | 2.0551376 |
Snippet | In this study antibacterial, antifungal and cytotoxic effects of some new 2,3-disubstituted 4(3H)-quinazolinone derivatives have been evaluated. The in vitro... In this study antibacterial, antifungal and cytotoxic effects of some new 2,3-disubstituted 4(3H)-quinazolinone derivatives have been evaluated. The in vitro... |
SourceID | pubmedcentral proquest pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 151 |
SubjectTerms | Original |
Title | Antibacterial, antifungal and cytotoxic evaluation of some new 2,3-disubstituted 4(3H)-quinazolinone derivatives |
URI | https://www.ncbi.nlm.nih.gov/pubmed/23181093 https://search.proquest.com/docview/1220570021 https://pubmed.ncbi.nlm.nih.gov/PMC3501924 |
Volume | 7 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEB7anryIb-uLFaQodG3a3STboxSlCJUeFLyVZB8YsUk1qVh_vbN5WCuePCfZDTszu9-w33wDcOYFyjXKN9QzIaPcdRwqmPKp4n3f9AVCkLxN5-jOGz7w20f3sQZuVQuTk_ZlGF3GL9PLOHrKuZWzqexUPLHOeDSwl2GYN3TqUEcH_ZGiPxeQ14ri5YWQzKUu7tBW8Rd91yon_QUkf_MhfxwwNxuwXiJDclX8wSbUdLwFrXEhLb1ok_tlpVTaJi0yXopOL7ZhdhVnUVhILwcvbRJYEhAGMo4YxIrIRZZkyUckyVLemySGpMlUE0TWpNdmVEUpbiMFd0ARfs6GF_R1HsXBp-3sk8SaKBz9PZcKT3fg4eb6fjCkZTcFOsNDOMMcUfa7XDPHeEr5vuI2HQ1tyPaMwjyY9xmi7Z7yRYAxbwQXsiuN7IVaaI5GZLvQsFPtA-HGMUJJ7gSex626AMIMFy3LuCOkFqoJp9UiT9Bb7RVEEOtknk66tq7Xt8CiCXvFok9mhazGpDJRE_wVc3y_YJWwV5-gg-SK2KVDHPz7y0NYQyRU8nCPoJG9zfUxoo0sPIH6iIuT3Me-AC732eY |
link.rule.ids | 230,315,730,783,787,888,2228,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwEB2xHOCC2CmrkRACqW7T2kncI0KgshT1UCRuUeJFBNGkkBRRvp5x0lJAnDgnsSPPjP1GfvMG4MgLlWuUb6hnIka56zhUMOVTxVu-aQmEIEWbzs6d177n1w_uwwy4k1qYgrQvo7iWPPdrSfxYcCsHfVmf8MTq3c65vQzDvKE-C_MYrw7_lqQ_laDXyuIVpZDMpS7u0VbzF73Xaif9BSV_MyK_HTGXy7A0xobkrPyHFZjRySocd0tx6VGV9Ka1UlmVHJPuVHZ6tAaDsySPo1J8OXyuktDSgDCUccQwUUSO8jRP32NJpgLfJDUkS_uaILYmzSqjKs5wIynZA4rwE9Y-pS_DOAk_bG-fNNFE4ehvhVh4tg73lxe98zYd91OgAzyGc8wSZavBNXOMp5TvK24T0sgGbdMozIR5iyHebipfhBj1RnAhG9LIZqSF5mhGtgFzdqotINw4RijJndDzuNUXQKDhom0Zd4TUQlXgcLLIAfqrvYQIE50Os6BhK3t9Cy0qsFkuejAohTWCiYkq4P8wx9cLVgv75xN0kUITe-wS2__-8gAW2r3ObXB7dXezA4uIi8as3F2Yy1-Heg-xRx7tF572Cap23GI |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS8MwFA46QXwR785rBBGFxXVL2maPYzrmZWMPCr6VNhesuLbaTpy_3pN2c5v45HPbpOSck3yHfOc7CJ06vrS1dDVxdEAJsy2LcCpdIlnD1Q0OECRv09ntOZ1HdvtkP820-spJ-yIIL6PXwWUUPufcymQgqhOeWLXfbZnLMMgbqonU1UW0BDFrOTOJ-ksBfI00Xl4OSW1iwz5tdH_Bg41-0l9w8jcrcuaYaa-h1TE-xM3iP9bRgoo20Fm_EJgeVfDDtF4qreAz3J9KT482UdKMsjAoBJj91wr2DRUIwhlG9COJxSiLs_gzFHgq8o1jjdN4oDDga1yvUCLDFDaTgkEgMTunnQvyNgwj_8v094kjhSWM_pELhqdb6LF9_dDqkHFPBZLAUZxBpigaNaaopR0pXVcyk5QGJnDrWkI2zBoUMHddutyHyNeccVETWtQDxRUDU9JtVDJT7SLMtKW5FMzyHYcZjQEAGzbYlzKLC8VlGZ1MFtkDnzUXEX6k4mHq1Ux1r2vgRRntFIvuJYW4hjcxURm5c-b4ecHoYc8_ATfJdbHHbrH37y-P0XL_qu3d3_Tu9tEKQKMxMfcAlbL3oToE-JEFR7mjfQPPcN11 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antibacterial%2C+antifungal+and+cytotoxic+evaluation+of+some+new+2%2C3-disubstituted+4%283H%29-quinazolinone+derivatives&rft.jtitle=Research+in+pharmaceutical+sciences&rft.au=Khodarahmi%2C+G.A.&rft.au=Khajouei%2C+M.+Rahmani&rft.au=Hakimelahi%2C+G.H.&rft.au=Abedi%2C+D.&rft.date=2012-07-01&rft.pub=Medknow+Publications+%26+Media+Pvt+Ltd&rft.issn=1735-5362&rft.eissn=1735-9414&rft.volume=7&rft.issue=3&rft.spage=151&rft.epage=158&rft_id=info%3Apmid%2F23181093&rft.externalDBID=PMC3501924 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1735-5362&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1735-5362&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1735-5362&client=summon |